戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n the PGRN gene present with neuronal ceroid lipofuscinosis.
2  storage disorder, infantile neuronal ceroid lipofuscinosis.
3 enerative disorder infantile neuronal ceroid lipofuscinosis.
4 valent in Finland, infantile neuronal ceroid lipofuscinosis.
5 platelet storage-pool deficiency, and ceroid lipofuscinosis.
6 s of patients with infantile neuronal ceroid lipofuscinosis.
7 enerative disorder infantile neuronal ceroid lipofuscinosis.
8 nerative disorder, infantile neuronal ceroid lipofuscinosis.
9 beneficial for patients with neuronal ceroid lipofuscinosis.
10 erative disorder adult-onset neuronal ceroid lipofuscinosis.
11  treatment of late infantile neuronal ceroid lipofuscinosis.
12 Pick type A/B, and infantile neuronal ceroid lipofuscinosis.
13 e genetic models of juvenile neuronal ceroid lipofuscinosis.
14 h the classic late infantile neuronal ceroid lipofuscinosis.
15 an disorder called infantile neuronal ceroid lipofuscinosis.
16 ipofuscinosis was designated neuronal ceroid lipofuscinosis-11 (CLN11).
17 e (or classic late infantile neuronal ceroid lipofuscinosis), a paediatric neurodegenerative disease
18 enerative disorder infantile neuronal ceroid lipofuscinosis, a disease characterized by accumulation
19 etected in two patients with neuronal ceroid lipofuscinosis, a lysosomal storage disease.
20 ad to classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage di
21 lly associated with juvenile neuronal ceroid lipofuscinosis, a rare neurodegenerative disease with ea
22 an autosomal dominant, adult-neuronal ceroid lipofuscinosis (AD-ANCL).
23 nerative disorder, infantile neuronal ceroid lipofuscinosis (also known as infantile Batten disease).
24                         Adult onset neuronal lipofuscinosis (ANCL) is a human neurodegenerative disor
25 tosomal-dominant adult-onset neuronal ceroid lipofuscinosis (ANCL) is caused by mutation of the DNAJC
26 atten disease, also known as juvenile ceroid-lipofuscinosis and CLN3, is an autosomal recessively inh
27  a mouse model for infantile neuronal ceroid lipofuscinosis and further suggest that PPT2 serves a ro
28 ge diseases Niemann-Pick and neuronal ceroid lipofuscinosis and have been reported to regulate choles
29 natural history of infantile neuronal ceroid lipofuscinosis and that of affected older siblings.
30 in-43-positive lesions were observed, robust lipofuscinosis and ubiquitination in GRN(-/-) mice is st
31 ulation of ubiquitinated protein aggregates, lipofuscinosis, and endolysosomal abnormalities.
32 nerative disorder, infantile neuronal ceroid lipofuscinosis, and lipid thioesters derived from acylat
33 tion of new animal models of neuronal ceroid lipofuscinosis, and the impact of novel methodology to r
34 lexia, Aicardi syndrome, and neuronal ceroid lipofuscinosis are presented.
35 pathological features of the neuronal ceroid lipofuscinosises: autofluorescent inclusions and lysosom
36  the first signs of juvenile neuronal ceroid lipofuscinosis caused by CLN3 mutations, followed by ine
37     Classical late infantile neuronal ceroid lipofuscinosis (cLINCL) is a lysosomal storage disorder
38 en, classical late-infantile neuronal ceroid lipofuscinosis (cLINCL).
39 somal disease late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).
40 rder, classic late infantile neuronal ceroid lipofuscinosis (CLN2).
41 hood, classic late infantile neuronal ceroid lipofuscinosis (CLN2).
42 sh variant of late infantile neuronal ceroid lipofuscinosis (CLN5 disease) belongs to a family of neu
43 duced classic late infantile neuronal ceroid lipofuscinosis disease-associated mutation, G77R, signif
44 ative disease late infantile neuronal ceroid lipofuscinosis encodes a lysosomal protease with tripept
45 ase-associated gene ATP13A2, neuronal ceroid lipofuscinosis gene TPP1 and the hereditary motor and se
46 or six of the eight forms of neuronal ceroid lipofuscinosis have now been discovered, and concerted e
47 e development of adult-onset neuronal ceroid lipofuscinosis in affected families.
48                    Infantile neuronal ceroid lipofuscinosis (INCL) is a devastating childhood neurode
49                    Infantile neuronal ceroid lipofuscinosis (INCL) is a devastating childhood neurode
50                The infantile neuronal ceroid lipofuscinosis (INCL) is a devastating neurodegenerative
51                    Infantile neuronal ceroid lipofuscinosis (INCL) is a devastating, neurodegenerativ
52                    Infantile neuronal ceroid lipofuscinosis (INCL) is a fatal neurodegenerative disor
53                    Infantile neuronal ceroid lipofuscinosis (INCL) is a pediatric neurodegenerative d
54                    Infantile neuronal ceroid lipofuscinosis (INCL) is an inherited childhood neurodeg
55                    Infantile neuronal ceroid lipofuscinosis (INCL) is an inherited neurodegenerative
56                    Infantile neuronal ceroid lipofuscinosis (INCL) is an inherited neurodegenerative
57                    Infantile neuronal ceroid lipofuscinosis (INCL) is caused by palmitoyl protein thi
58 he PPT1 gene cause infantile neuronal ceroid lipofuscinosis (INCL), a devastating neurodegenerative s
59                    Infantile neuronal ceroid lipofuscinosis (INCL), a neurodegenerative storage disor
60                The infantile neuronal ceroid lipofuscinosis (INCL), a rare (one in 100 000 births) bu
61 T in patients with infantile neuronal ceroid lipofuscinosis (INCL), a severe neurodegenerative disord
62 e (PPT) gene cause infantile neuronal ceroid lipofuscinosis (INCL), the clinical manifestations of wh
63                    Infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease) is a neu
64                    Infantile neuronal ceroid lipofuscinosis (INCL, or CLN1 disease) is an inherited n
65              Two mRNAs were linked to ceroid lipofuscinosis, indicating a potential role for alphaCP2
66                    Infantile neuronal ceroid lipofuscinosis is a devastating neurodegenerative lysoso
67               Late infantile neuronal ceroid lipofuscinosis is a fatal childhood neurological disorde
68     Classical late-infantile neuronal ceroid lipofuscinosis is a fatal neurodegenerative disease caus
69                     Juvenile neuronal ceroid lipofuscinosis is a severe inherited neurodegenerative d
70                     Juvenile neuronal ceroid lipofuscinosis is caused by mutation of a novel, endosom
71 al enzyme and that infantile neuronal ceroid lipofuscinosis is properly classified as a lysosomal sto
72  (formerly known as juvenile neuronal ceroid lipofuscinosis) is a fatal childhood neurodegenerative d
73                     Juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease) caused by mutati
74                     Juvenile neuronal ceroid lipofuscinosis (JNCL or Batten Disease) is one of the mo
75 agy specifically in juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease), a neurodegenera
76 the CLN3 gene cause juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease), an early onset
77                     Juvenile neuronal ceroid lipofuscinosis (JNCL) is a fatal childhood-onset neurode
78                     Juvenile neuronal ceroid lipofuscinosis (JNCL) is a fatal lysosomal storage disea
79                     Juvenile neuronal ceroid lipofuscinosis (JNCL) is a fatal lysosomal storage disea
80                     Juvenile neuronal ceroid lipofuscinosis (JNCL), Batten disease, is an autosomal r
81                     Juvenile neuronal ceroid lipofuscinosis (JNCL), or Batten disease, is a neurodege
82                     Juvenile neuronal ceroid lipofuscinosis (JNCL), or juvenile Batten disease, is a
83  Batten disease, or juvenile neuronal ceroid lipofuscinosis (JNCL), results from mutations in the CLN
84  protracted form of juvenile neuronal ceroid lipofuscinosis (JNCL).
85               Juvenile-onset neuronal ceroid lipofuscinosis (JNCL; Batten disease) features hallmark
86 tten disease (juvenile-onset neuronal ceroid lipofuscinosis [JNCL]) is an autosomal recessive conditi
87 agy is disrupted in juvenile neuronal ceroid lipofuscinosis, likely at the level of autophagic vacuol
88     Classical late-infantile neuronal ceroid lipofuscinosis (LINCL) is a fatal neurodegenerative dise
89       Classic late infantile neuronal ceroid lipofuscinosis (LINCL) is a neurodegenerative disease in
90   The late-infantile form of neuronal ceroid lipofuscinosis (LINCL) is a progressive and ultimately f
91  in classical late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal childhood neurodegenerat
92 rage disorder Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL).
93 The classical late infantile neuronal ceroid lipofuscinosis (LINCLs) is an autosomal recessive diseas
94                              Neuronal ceroid lipofuscinosis (NCL) comprises approximately 13 genetica
95 ave shown that patients with neuronal ceroid lipofuscinosis (NCL) develop neurodegeneration character
96              Mouse models of neuronal ceroid lipofuscinosis (NCL) exhibit many features of the human
97                              Neuronal ceroid lipofuscinosis (NCL) is a genetically heterogeneous grou
98               Late infantile neuronal ceroid lipofuscinosis (NCL) is an inherited disorder characteri
99                 A subtype of neuronal ceroid lipofuscinosis (NCL) is well recognized which has a clin
100 generative diseases known as neuronal ceroid lipofuscinosis (NCL) or Batten disease has been identifi
101 escribe the ninth variant of neuronal ceroid lipofuscinosis (NCL) or Batten disease, due to defects i
102 utation may also model human neuronal ceroid lipofuscinosis (NCL) or Batten disease.
103 he neurodegenerative disease neuronal ceroid lipofuscinosis (NCL), accumulated throughout the CNS but
104                              Neuronal ceroid lipofuscinosis (NCL), commonly referred to as Batten dis
105 order of children, infantile neuronal ceroid lipofuscinosis (NCL).
106  storage disorder, infantile neuronal ceroid lipofuscinosis (NCL).
107 e lysosomal storage disorder neuronal ceroid lipofuscinosis (NCL).
108 -43)-positive inclusions and neuronal ceroid lipofuscinosis (NCL).
109 for-Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis (NCL).
110  lysosomal storage disorder, neuronal ceroid lipofuscinosis (NCL).
111 lly occurring ovine model of neuronal ceroid lipofuscinosis (NCL, Batten disease) caused by a mutatio
112 ease) belongs to a family of neuronal ceroid lipofuscinosis (NCLs) diseases.
113 l muscular atrophy (SMA) and neuronal ceroid lipofuscinosis (NCLs).
114 ative disorder caused by mutations in ceroid lipofuscinosis neuronal-3 (CLN3), a hydrophobic transmem
115 age diseases, including NPC2, Batten (ceroid lipofuscinosis, neuronal 2, CLN2), Fabry, Farber, Nieman
116 ase resulting from mutations in CLN3 (ceroid-lipofuscinosis, neuronal 3, juvenile).
117  ten children with infantile neuronal ceroid lipofuscinosis; one child was lost to follow-up after th
118 generative disorder juvenile neuronal ceroid lipofuscinosis or Batten disease.
119 y of patients with infantile neuronal ceroid lipofuscinosis provides a guide for future assessment of
120                             Lysosomal ceroid lipofuscinosis, pulmonary fibrosis and granulomatous col
121 is associated with a form of neuronal ceroid lipofuscinosis, suggesting that PPT1 and -2 perform non-
122 erent neurological disorder, neuronal ceroid lipofuscinosis, suggesting that the total absence of pro
123 1X) mouse model of infantile neuronal ceroid lipofuscinosis that we have generated.
124 led profile of the impact of neuronal ceroid lipofuscinosis upon the brain.
125 auses variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), a recessively inherited neurode
126 l for variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), a severe and devastating multis
127 for this form of adult onset neuronal ceroid lipofuscinosis was designated neuronal ceroid lipofuscin
128  cause the infantile form of neuronal ceroid lipofuscinosis, which is a lysosomal storage disorder ch
129 be responsible for infantile neuronal ceroid lipofuscinosis, which is a severe brain disorder charact
130 g 32 unrelated families with neuronal ceroid lipofuscinosis who had GROD documented morphologically.
131  years of age with infantile neuronal ceroid lipofuscinosis with any two of the seven most lethal PPT
132 implicated in late infantile neuronal ceroid lipofuscinosis with iodine-124.
133 ce causes an unusual form of neuronal ceroid lipofuscinosis with striking visceral manifestations.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top